No Data
No Data
ANI's Generic L-Glutamine Oral Powder Hits Market, Targets $20.1M Annual Sales
ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ:ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (
Express News | ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder
ANI Pharmaceuticals (NASDAQ:ANIP) Shareholder Returns Have Been Decent, Earning 95% in 3 Years
By buying an index fund, you can roughly match the market return with ease. But if you buy good businesses at attractive prices, your portfolio returns could exceed the average market return. Just
ANI Pharmaceuticals(ANIP.US) Officer Sells US$1.27 Million in Common Stock
$ANI Pharmaceuticals(ANIP.US)$ Officer Gassert Chad sold 20,000 shares of common stock on Jul 1, 2024 at an average price of $63.44 for a total value of $1.27 million.Source: Announcement What is stat
Express News | Corrected-ANI Pharmaceuticals - U.S. Annual Sales for Naproxen Tablets About $36.7 Mln, Based on April Mat IQVIA Data (Adds Dropped Words 'based on April Mat IQVIA Data')
Express News | ANI Pharmaceuticals Announces FDA Approval And Launch Of Its Naproxen Delayed-Release Tablets, USP